Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

IGM Biosciences

NASDAQ IGMS
$10.12 0.78 7.71%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

605.47M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
498.78M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-1.05
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
59.83M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
21.78 %

Upcoming events IGM Biosciences

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart IGM Biosciences

Stock analysis IGM Biosciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-2.46 21.90
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
2.98 3.49
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-1.95 9.18
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.42 -0.17
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-121.25 10.75

Price change IGM Biosciences per year

42.00$ 127.11$
Min Max

Summary analysis IGM Biosciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure IGM Biosciences

Revenue and net income IGM Biosciences

All parameters

Stock news IGM Biosciences

All news
6 December 2023 в 02:50

Stocks to Watch: SentinelOne, MongoDB, IGM Biosciences

6 December 2023 в 02:50

Stocks to Watch: SentinelOne, MongoDB, IGM Biosciences

6 December 2023 в 00:32

IGM Biosciences to Reduce Workforce by 22% Amid Broader Restructuring

6 December 2023 в 00:31

IGM Biosciences to Reduce Workforce by 22% Amid Broader Restructuring

22 June 2023 в 18:15

IGM Biosciences Shares Rise 13% After Public Offering Prices

22 June 2023 в 18:15

IGM Biosciences Shares Rise 13% After Public Offering Prices

8 April 2022 в 23:30

Nielson, IGM Biosciences, and, Yes, Twitter, See Activist Action

29 March 2022 в 19:11

IGM Biosciences Shares Continue to Surge on Sanofi Deal >IGMS

29 March 2022 в 19:11

IGM Biosciences Shares Continue to Surge on Sanofi Deal >IGMS

29 March 2022 в 13:10

IGM Biosciences Shares Soar Premarket on Sanofi Collaboration >IGMS

29 March 2022 в 13:00

IGM Biosciences Shares Soar Premarket on Sanofi Collaboration >IGMS

13 December 2021 в 20:45

IGM Biosciences Shares Drop 47% After Data for Cancer Treatment

13 December 2021 в 20:45

IGM Biosciences Shares Drop 47% After Data for Cancer Treatment

26 August 2021 в 17:00

IGM Biosciences started at overweight at Morgan Stanley

About company IGM Biosciences

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of multiple diseases. Its lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 1 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). The company is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers and NHL; and IGM-7354, is a bispecific IgM antibody delivering interleukin-15 cytokines to PD-L1 expressing cells for use in the treatment of patients with solid and hematologic malignancies. It has a strategic research and license agreement with AbCellera to discover and develop IgM antibodies; and license agreement with AvantGen Inc. for various antibodies against the SARS-CoV-2 virus. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
Address:
325 East Middlefield Road, Mountain View, CA, United States, 94043
Company name: IGM Biosciences
Issuer ticker: IGMS
ISIN: US4495851085
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-09-18
Sector: Healthcare
Industry: Biotechnology
Site: https://igmbio.com

On which stock exchange are IGM Biosciences (IGMS) stocks traded?

IGM Biosciences (IGMS) stocks are traded on NASDAQ.

What is the ticker of IGM Biosciences stocks (IGMS)?

The stock ticker of IGM Biosciences’s stocks or in other words, the code is IGMS. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does IGM Biosciences (IGMS) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, IGM Biosciences (IGMS) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are IGM Biosciences (IGMS) stocks traded?

IGM Biosciences (IGMS) stocks are traded on the NASDAQ exchange in dollars.

What is the price of IGM Biosciences (IGMS) stocks today?

The current price of IGM Biosciences stocks on 10.05.2024 is 10.12 dollars. per share.

What is the dynamics of IGM Biosciences (IGMS) stocks from the beginning of the year?

IGM Biosciences (IGMS) quotes have increased by 16.59% from the beginning of the year up to 10.12 dollars. per 1 stocks.

How much did IGM Biosciences (IGMS) stocks increase in мае 2024?

This month IGM Biosciences (IGMS) quotes have increased by 6.75% to 10.12 dollars. per share.

How much are IGM Biosciences (IGMS) stocks worth?

Today, on October, 10.05.2024 IGM Biosciences’s (IGMS) stocks cost 10.12 dollars..

What is the market capitalization of IGM Biosciences (IGMS)?

Capitalization is the market value of IGM Biosciences (IGMS) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 10.05.2024, the market capitalization of IGM Biosciences (IGMS) is estimated at about 605470259 dollars.